Search results for:
insulin aspart
insulin aspart
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Fiasp |
DEVICE, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
Merilog |
INJECTION, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
NovoLOG |
SOLUTION, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
Last updated: Jul. 18, 2025
NovoLOG, Fiasp & Merilog are approved for sample use in HH Endocrinology and Diabetes Clinics.
NovoLOG is interchanged to HumaLOG on a unit per unit basis.
Fiasp and Merilog are interchanged to HumaLOG on a unit per unit basis.
Approved to round DOWN to nearest whole unit if calculations result in dose in fractions.
Patients with orders for the hospital’s adult sliding scale insulin order set have orders to implement the hospital’s hypoglycemia orders. However, some patients have orders for scheduled or PRN insulin without use of the sliding scale insulin order set. These patients may not have PRN orders for treatment of hypoglycemia.
To improve safety with insulin use, the following policy has been approved by the P&T Committee:
Reviewed: 27 March 2018 (Fiasp) June 2025 (Merilog)
Insulin aspart-szjj (MERILOG) Spotlight.pdf